Cargando…
Editorial: Immunotherapy and small molecule inhibitors as combinational cancer therapeutics
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478216/ https://www.ncbi.nlm.nih.gov/pubmed/37675110 http://dx.doi.org/10.3389/fimmu.2023.1270182 |
_version_ | 1785101298528419840 |
---|---|
author | Khan, Mohd Wajid Ali Aziz, Mohammad Azhar Rajendrasozhan, Saravanan |
author_facet | Khan, Mohd Wajid Ali Aziz, Mohammad Azhar Rajendrasozhan, Saravanan |
author_sort | Khan, Mohd Wajid Ali |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10478216 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104782162023-09-06 Editorial: Immunotherapy and small molecule inhibitors as combinational cancer therapeutics Khan, Mohd Wajid Ali Aziz, Mohammad Azhar Rajendrasozhan, Saravanan Front Immunol Immunology Frontiers Media S.A. 2023-08-22 /pmc/articles/PMC10478216/ /pubmed/37675110 http://dx.doi.org/10.3389/fimmu.2023.1270182 Text en Copyright © 2023 Khan, Aziz and Rajendrasozhan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Khan, Mohd Wajid Ali Aziz, Mohammad Azhar Rajendrasozhan, Saravanan Editorial: Immunotherapy and small molecule inhibitors as combinational cancer therapeutics |
title | Editorial: Immunotherapy and small molecule inhibitors as combinational cancer therapeutics |
title_full | Editorial: Immunotherapy and small molecule inhibitors as combinational cancer therapeutics |
title_fullStr | Editorial: Immunotherapy and small molecule inhibitors as combinational cancer therapeutics |
title_full_unstemmed | Editorial: Immunotherapy and small molecule inhibitors as combinational cancer therapeutics |
title_short | Editorial: Immunotherapy and small molecule inhibitors as combinational cancer therapeutics |
title_sort | editorial: immunotherapy and small molecule inhibitors as combinational cancer therapeutics |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478216/ https://www.ncbi.nlm.nih.gov/pubmed/37675110 http://dx.doi.org/10.3389/fimmu.2023.1270182 |
work_keys_str_mv | AT khanmohdwajidali editorialimmunotherapyandsmallmoleculeinhibitorsascombinationalcancertherapeutics AT azizmohammadazhar editorialimmunotherapyandsmallmoleculeinhibitorsascombinationalcancertherapeutics AT rajendrasozhansaravanan editorialimmunotherapyandsmallmoleculeinhibitorsascombinationalcancertherapeutics |